StockData
LivaNova PLC logo

LivaNova PLC (LIVN) KPIs and segments

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

KPIs & segments

Operating metrics and segments that drive LivaNova's business

LivaNova's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

LivaNova's fiscal year ends December 31 — Q2 2026 = CQ2 2026 (calendar quarter).

Periods
Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Cardiopulmonary($M)3
222209207203199176182172174156165149
Rest of World($M)
86.882.177.381.279.071.069.568.870.364.458.661.2
United States($M)
72.869.371.871.971.260.864.562.564.950.660.552.3
Europe($M)
62.057.357.450.149.044.547.640.938.640.946.235.5
Neuromodulation($M)3
167152153150152139138140143134137129
United States($M)
127115120118117108111113112106106102
Rest of World($M)
20.518.015.516.616.715.413.115.015.614.514.113.7
Europe($M)
19.918.317.614.517.715.214.011.915.613.416.412.7
Earlier reporting (last reported 2023)1
United States($M)
199185191190188169175180180161173162
Rest of World($M)
10910294.499.697.388.085.185.587.880.074.476.4
Europe($M)
81.875.775.067.766.859.761.652.851.354.362.648.1
Neuromodulation($M)
60.944.250.956.256.052.444.349.5
Cardiopulmonary($M)
28.230.127.524.731.424.720.821.7
Neuromodulation($M)
152138138137137126121128131124
Cardiopulmonary($M)
12410810310510491.491.291.387.179.6
Neuromodulation($M)
-7.78-8.84-4.85-4.74-4.22-2.03-1.86-1.38-0.73-0.28-0.11-0.60
Cardiopulmonary($M)
-12.5-10.4-21.1-9.50-8.77-5.17-9.43-7.38-7.53-3.75-10.9-4.14
Cardiopulmonary($M)
1,0511,0461,0451,0191,014940901967934943962
Neuromodulation($M)
652650640640638642641635640652647
Earlier reporting (last reported 2023)1

28 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-05.

See a number that looks wrong?